• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素衍生物SDZ PSC 833对阿霉素和长春碱经人P-糖蛋白转运的抑制作用。

Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.

作者信息

Kusunoki N, Takara K, Tanigawara Y, Yamauchi A, Ueda K, Komada F, Ku Y, Kuroda Y, Saitoh Y, Okumura K

机构信息

First Department of Surgery, School of Medicine, Kobe University.

出版信息

Jpn J Cancer Res. 1998 Nov;89(11):1220-8. doi: 10.1111/j.1349-7006.1998.tb00518.x.

DOI:10.1111/j.1349-7006.1998.tb00518.x
PMID:9914792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5921725/
Abstract

The inhibitory effects of SDZ PSC 833 (PSC833), a non-immunosuppressive cyclosporin derivative, on the P-glycoprotein (P-gp)-mediated transport of doxorubicin and vinblastine were compared with those of cyclosporin A (Cs-A). The transcellular transport of the anticancer drugs and PSC833 across a monolayer of LLC-GA5-COL150 cells, which overexpress human P-gp, was measured. Both PSC833 and Cs-A inhibited P-gp-mediated transport of doxorubicin and vinblastine in a concentration-dependent manner and increased the intracellular accumulation of doxorubicin and vinblastine in LLC-GA5-COL150 cells. The values of the 50%-inhibitory concentration (IC50) of PSC833 and Cs-A for doxorubicin transport were 0.29 and 3.66 microM, respectively, and those for vinblastine transport were 1.06 and 5.10 microM, respectively. The IC50 of PSC833 for doxorubicin transport was about 4-fold less than that for vinblastine transport, suggesting that the combination of PSC833 and doxorubicin might be effective. PSC833 itself was not transported by P-gp and had higher lipophilicity than Cs-A. These results indicated that the inhibitory effect of PSC833 on P-gp-mediated transport was 5- to 10-fold more potent than that of Cs-A, and this higher inhibitory effect of PSC833 may be related to the absence of PSC833 transport by P-gp and to the higher lipophilicity of PSC833.

摘要

将非免疫抑制性环孢素衍生物SDZ PSC 833(PSC833)对P-糖蛋白(P-gp)介导的阿霉素和长春碱转运的抑制作用与环孢素A(Cs-A)进行了比较。测定了抗癌药物和PSC833在过表达人P-gp的LLC-GA5-COL150细胞单层上的跨细胞转运。PSC833和Cs-A均以浓度依赖性方式抑制P-gp介导的阿霉素和长春碱转运,并增加了LLC-GA5-COL150细胞中阿霉素和长春碱的细胞内蓄积。PSC833和Cs-A对阿霉素转运的50%抑制浓度(IC50)值分别为0.29和3.66 microM,对长春碱转运的IC50值分别为1.06和5.10 microM。PSC833对阿霉素转运的IC50约比对长春碱转运的IC50小4倍,提示PSC833与阿霉素联合可能有效。PSC833本身不被P-gp转运,且比Cs-A具有更高的亲脂性。这些结果表明,PSC833对P-gp介导转运的抑制作用比Cs-A强5至10倍,PSC833的这种更高抑制作用可能与PSC833不被P-gp转运以及其更高的亲脂性有关。

相似文献

1
Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.环孢素衍生物SDZ PSC 833对阿霉素和长春碱经人P-糖蛋白转运的抑制作用。
Jpn J Cancer Res. 1998 Nov;89(11):1220-8. doi: 10.1111/j.1349-7006.1998.tb00518.x.
2
Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein.环孢素类似物和FK506对柔红霉素和长春碱经P-糖蛋白的跨细胞转运的影响。
Pharm Res. 1996 Jul;13(7):1073-7. doi: 10.1023/a:1016019010339.
3
Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.伊曲康唑对P-糖蛋白介导的抗癌药物耐药性逆转作用的细胞药代动力学方面
Biol Pharm Bull. 1999 Dec;22(12):1355-9. doi: 10.1248/bpb.22.1355.
4
Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.维拉帕米、环孢素A和SDZ PSC 833对P-糖蛋白介导的长春碱跨HCT-8肠癌细胞单层转运的抑制作用与细胞外pH的关系
Cancer Chemother Pharmacol. 1994;34(2):125-32. doi: 10.1007/BF00685929.
5
Interaction of docetaxel ("Taxotere") with human P-glycoprotein.多西他赛(“泰索帝”)与人P-糖蛋白的相互作用。
Jpn J Cancer Res. 1999 Dec;90(12):1380-6. doi: 10.1111/j.1349-7006.1999.tb00723.x.
6
The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.新型抗癌药物KRN5500与人P-糖蛋白相互作用,但几乎不被其转运。
Jpn J Cancer Res. 2000 Feb;91(2):248-54. doi: 10.1111/j.1349-7006.2000.tb00938.x.
7
Inhibitory effect of cyclosporin A on p-glycoprotein function in peripheral nerves of mice treated with doxorubicin and vinblastine.环孢素A对阿霉素和长春碱处理的小鼠外周神经中P-糖蛋白功能的抑制作用。
Acta Otolaryngol. 2004 Apr;124(3):313-7. doi: 10.1080/00016480310005093.
8
Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.α-肾上腺素能受体拮抗剂多沙唑嗪对多药耐药基因1(MDR1)介导的多药耐药及跨细胞转运的影响
Oncol Res. 2009;17(11-12):527-33. doi: 10.3727/096504009789745601.
9
P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.在体外培养的HCT-8癌细胞中,P-糖蛋白介导的多药耐药性可通过化疗增敏剂预处理来调节。
Int J Oncol. 1998 May;12(5):1137-42. doi: 10.3892/ijo.12.5.1137.
10
Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.卡维地洛对多药耐药基因1(MDR1)介导的多药耐药的影响:与维拉帕米的比较。
Cancer Sci. 2003 Jan;94(1):81-6. doi: 10.1111/j.1349-7006.2003.tb01356.x.

引用本文的文献

1
Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients.预测非酒精性脂肪性肝炎患者药物药代动力学的改变及药物不良反应风险
Acta Pharm Sin B. 2023 Jan;13(1):1-28. doi: 10.1016/j.apsb.2022.08.018. Epub 2022 Aug 28.
2
Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance.NSC23925的新型喹啉化合物衍生物作为P-糖蛋白介导的多药耐药的有效逆转剂
Front Chem. 2019 Dec 19;7:820. doi: 10.3389/fchem.2019.00820. eCollection 2019.
3
Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.血脑屏障处P-糖蛋白对海洛因及其主要代谢产物摄取的影响:行为效应以及对转录反应和强化特性的影响
Psychopharmacology (Berl). 2014 Aug;231(16):3139-49. doi: 10.1007/s00213-014-3490-9. Epub 2014 Apr 5.
4
Shear stress activation of nuclear receptor PXR in endothelial detoxification.剪切力激活核受体 PXR 在内皮解毒中的作用。
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13174-9. doi: 10.1073/pnas.1312065110. Epub 2013 Jul 22.
5
Increased affinity to canalicular P-gp via formation of lipophilic ion-pair complexes with endogenous bile salts is associated with mw threshold in hepatobiliary excretion of quaternary ammonium compounds.通过与内源性胆盐形成亲脂性离子对复合物,增加了对胆小管 P-糖蛋白的亲和力,这与季铵化合物在肝胆排泄中的 mw 阈值有关。
Pharm Res. 2010 May;27(5):823-31. doi: 10.1007/s11095-010-0075-0. Epub 2010 Mar 10.
6
Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.1,4-二氢吡啶类钙拮抗剂对P-糖蛋白介导转运的抑制效能:与对CYP3A4影响的比较。
Pharm Res. 2000 Oct;17(10):1189-97. doi: 10.1023/a:1007568811691.
7
The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.新型抗癌药物KRN5500与人P-糖蛋白相互作用,但几乎不被其转运。
Jpn J Cancer Res. 2000 Feb;91(2):248-54. doi: 10.1111/j.1349-7006.2000.tb00938.x.
8
Interaction of docetaxel ("Taxotere") with human P-glycoprotein.多西他赛(“泰索帝”)与人P-糖蛋白的相互作用。
Jpn J Cancer Res. 1999 Dec;90(12):1380-6. doi: 10.1111/j.1349-7006.1999.tb00723.x.

本文引用的文献

1
Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia.米托蒽醌加依托泊苷联合SDZ PSC - 833多药阻断用于复发或难治性急性髓性白血病的I期研究
J Clin Oncol. 1997 May;15(5):1796-802. doi: 10.1200/JCO.1997.15.5.1796.
2
Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.人MDR1基因转染的LLC-PK1细胞中P-糖蛋白表达水平与柔红霉素转运的关系
Biochem Pharmacol. 1997 Mar 7;53(5):741-6. doi: 10.1016/s0006-2952(96)00810-6.
3
Molecular interactions of cyclosporin A with P-glycoprotein. Photolabeling with cyclosporin derivatives.环孢菌素A与P-糖蛋白的分子相互作用。用环孢菌素衍生物进行光标记。
J Biol Chem. 1997 Mar 7;272(10):6647-52. doi: 10.1074/jbc.272.10.6647.
4
Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.SDZ PSC 833联合VAD(长春新碱、阿霉素、地塞米松)逆转难治性多发性骨髓瘤的多药耐药性:一项I期研究
Leukemia. 1996 Nov;10(11):1741-50.
5
Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein.环孢素类似物和FK506对柔红霉素和长春碱经P-糖蛋白的跨细胞转运的影响。
Pharm Res. 1996 Jul;13(7):1073-7. doi: 10.1023/a:1016019010339.
6
Pharmacological considerations in the modulation of multidrug resistance.多药耐药性调控中的药理学考量
Eur J Cancer. 1996 Jun;32A(6):1082-8. doi: 10.1016/0959-8049(96)00111-6.
7
Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.多药耐药调节剂SDZ PSC 833([3'-酮基-Bmt1]-Val2]-环孢素)与P-糖蛋白的相互作用分析。
Oncol Res. 1995;7(12):603-10.
8
Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer.依托泊苷联合SDZ PSC 833作为癌症患者多药耐药调节剂的I期研究。
J Clin Oncol. 1996 Feb;14(2):610-8. doi: 10.1200/JCO.1996.14.2.610.
9
Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.环孢素A联合阿霉素的I期药代动力学研究
Cancer Res. 1993 Oct 15;53(20):4837-42.
10
Modulation of vinblastine resistance with cyclosporine: a phase I study.
Clin Pharmacol Ther. 1993 Oct;54(4):421-9. doi: 10.1038/clpt.1993.169.